Evidence map›Paper›PMID 9819434›Full record

ArticleMolecular and cellular biology1998

Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation.

S Wang, R N Ghosh, S P Chellappan

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 120 citations in OpenAlex.

  1. Systemic dual delivery of a tumor-inhibiting plasmid expressing p16 and shRaf.Biochemical and biophysical research communications · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  7. ETS-targeted therapy: can it substitute for MEK inhibitors?Clinical and translational medicine · 2017
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The clinical development of MEK inhibitors.Nature reviews. Clinical oncology · 2014
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 3 countries.

S WangDepartment of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
R N Ghosh
S P Chellappan
Columbia College · CA

Funding

E2F TRANSCRIPTION FACTOR AND TUMOR SUPPRESSIONR01CA063136 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI CHELLAPPAN, SRIKUMAR P · 1994 to 2007
$2.2M
NCI NIH HHS CA63136NCI NIH HHS R01 CA063136
6 · The paper itself

Abstract

Cells initiate proliferation in response to growth factor stimulation, but the biochemical mechanisms linking signals received at the cell surface receptors to the cell cycle regulatory molecules are not yet clear. In this study, we show that the signaling molecule Raf-1 can physically interact with Rb and p130 proteins in vitro and in vivo and that this interaction can be detected in mammalian cells without overexpressing any component. The binding of Raf-1 to Rb occurs subsequent to mitogen stimulation, and this interaction can be detected only in proliferating cells. Raf-1 can inactivate Rb function and can reverse Rb-mediated repression of E2F1 transcription and cell proliferation efficiently. The region of Raf-1 involved in Rb binding spanned residues 1 to 28 at the N terminus, and functional inactivation of Rb required a direct interaction. Serum stimulation of quiescent human fibroblast HSF8 cells led to a partial translocation of Raf-1 into the nucleus, where it colocalized with Rb. Further, Raf-1 was able to phosphorylate Rb in vitro quite efficiently. We believe that the physical interaction of Raf-1 with Rb is a vital step in the growth factor-mediated induction of cell proliferation and that Raf-1 acts as a direct link between cell surface signaling cascades and the cell cycle machinery.

Indexed as

Carrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsProteinsCell CycleCell DivisionCell LineCell NucleusE2F1 Transcription FactorE2F Transcription FactorsFluorescent Antibody TechniqueGenetic VectorsHumansMitogensPhosphoproteinsPhosphorylationCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsE2F1 protein, humanE2F1 Transcription FactorE2F Transcription FactorsMitogensPhosphoproteinsProteinsProto-Oncogene Proteins c-rafRBL2 protein, humanRetinoblastoma-Binding Protein 1Retinoblastoma-Like Protein p130Retinoblastoma ProteinTranscription Factor DP1Transcription Factors

Identifiers

PMID9819434
PMCPMC109329
OpenAlexW2160671188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.